Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$FLML - Data due before YE2014 so any day now! and a full calender for 2015! Sheff thank you. again its very hard to find info on these guys
$KBIO Oral and Poster Abstracts for the ASH poster session
https://ash.confex.com/ash/2014/webprogram/Paper75316.html
$IGXT has anyone notice this been slowly climbing everyday now? its was around .38 weeks ago
Last PR from the company below
ntelGenx and RedHill Biopharma Announce Acceptance for Review of European Marketing Application for RIZAPORT(TM) for Migraines
The German Federal Institute for Drugs and Medical Devices ("BfArM") has validated the European Marketing Authorization Application submitted for RIZAPORTâ„¢ and initiated its formal review of the application on November 25, 2014
IntelGenx and RedHill continue to work with the FDA to resolve the remaining Chemistry, Manufacturing and Controls ("CMC") issues and secure a compliant source of the raw material, in order to advance potential FDA approval of the U.S. New Drug Application submitted by the companies
RIZAPORTâ„¢ oral thin film formulation of rizatriptan for acute migraines presents an attractive therapeutic alternative for many migraine patients, including those suffering from migraine-related nausea, due to its convenient dosing, lack of need for water intake and pleasant flavoring
Saint Laurent, Quebec--(Newsfile Corp. - December 1, 2014) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx"), a Canadian drug delivery company focused on oral drug delivery, today announced, together with RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) ("RedHill"), an Israeli biopharmaceutical company primarily focused on late clinical-stage drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, that the German Federal Institute for Drugs and Medical Devices ("BfArM") validated the Marketing Authorization Application ("MAA") for RIZAPORTâ„¢, an oral thin film formulation of rizatriptan for acute migraines, and has initiated the formal review process of the application on November 25, 2014. BfArM's potential feedback regarding the MAA is expected during the second half of 2015.
http://www.intelgenx.com/investors/pressreleases/2014/2014-12-01.html
$POZN So its all down the drain now? even with all the DD we had and the company strong position? i see nothing changed fundamentally except the news from today.
$ETRM Sheff The short interest in the counter has grown to 15.88% of the total floated shares, should you believe this is somehow bearish sign?
$ADMS- Dont forget the $30M milestone payment if approved by FDA intop of the $130M they received from Actavis. They will also be eligible for royalties upto 5 years after the US launch date!
$LCI- LOL i held 20K from 3.95 and sold at 19. my longest long term holding ever. i think it was worth it. I dont think i would of have held till now.
$POZN Somewhat give me flash backs from $LCI 3 years ago. The company have good management, cash and equivalents of $38.4 million, $5.5M in accounts receivable, 32.1M common shares outstanding & no debt.Not to forget the 3Q14 income of $6.8M and the %50 reduced operating expenses from $7.4M to $3.6M last year 3Q. More on the money is VIMOVO!as The company royalty due to increase from 6% to 10% in 2016. all been said! The company is making all the right moves but still seems that no one cares at this point and the PPS still keep fading out. i miss the days when the runups to any none sense catalyst use make an easy 20% profit
CERS- is it true that the 11/21 date is no longer in play and the FDA have an ad-com scheduled for 12/2/14 to review the treatment of Ebola convalescent plasma
POZN-six-month Class 2 decision date on 12/30/14. the manufacturing inspection deficiencies of the the active ingredient API supplier was the only remaining issue! the company hired their own independent expert to review the manufacturing deficiencies correction. the company believes that they responded fully to issue(observation) raised by to address FDA. A harsh CRL seems very unlikely at this point! While the stock could keep on fading until the PDUFA decision goal, i still see the stock crossing over the $10 mark if approved. questions is, why there is no buyers at this point?
$CUR-Neuralstem NSI-189 Phase Ib Major Depression Disorder Neurogenic Biomarker Data Presented At The CNS Summit.
http://investor.neuralstem.com/2014-11-17-Neuralstem-NSI-189-Phase-Ib-Major-Depression-Disorder-Neurogenic-Biomarker-Data-Presented-At-The-CNS-Summit#cur
Thank you for the efforts putting such an informative post and the information you shared/ I appreciate it. ... This is really a fascinating stock that i don't seem to understand very well due to limited information out there.
$FLML shares went up almost 15% yesterday. some folks said that Suntrust confirmed that Bloxiverz price is $36 from $16 and the FDA halted competitor product shipments on 10/31/14. However, I'm unable to find any proves of that claim. The only thing i found today is Report of foreign issuer Rules 13a-16 and 15d-16 http://stks.co/i1J25 $FLML
$FLML looking so attractive. started a position and will load up on dips. I believe VAZCULEP sales will turn this company positive earnings growth during the 2015-16 period.( possible a little move on earning at the end of the month)
Thank you again Sir! can you please look into $FLML and let us know your thoughts
How about $BLUE are you still holding on this one? seems that everything crashing
$CERS 10/10 FDA decision day for the Expanded Access IDE is 2 weeks from now and the stocks is trading near lows! It should be a good runup from here and might reach upper $4 if they get the tumbs-up from the FDA. on side note about 65% of the shares held by institutional including Baker Bros. they are the largest shareholder of 10.2M shares and increased thier holding by around 21% in late August. I'm holding 5200 (thousand NOT millions)Shares.LOL who else is watching?
Thanks Sheff! I had my eyes on CLDX for while now! its defiantly a trader stocks that like to run without warnings and go down with IBB but,The price is in an established bearish trend at this time represented by the moving average period 21 week bars.so much volatility going on. and in this state, the price is likely in an established uptrend. However, im VERY bullish on the Intermediate-Term and know the price will move in the next weeks. buying at around 13.68 today seemed like the right thing to do untill i saw 13.17 ughh